FDA Approved: LAMPIT — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Lampit (nifurtimox) from Bayer HealthCare Pharmaceuticals Inc., signaling an update to its labeling/indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chagas Disease

Drugs mentioned

• Lampit (nifurtimox)

Snippet

SUPPL AP for LAMPIT (NIFURTIMOX)